BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhai H, Liu A, Huang W, Liu X, Feng S, Wu J, Yao Y, Wang C, Li Q, Hao Q, Hu J, Zhang S. Increasing rate of inflammatory bowel disease: a 12-year retrospective study in NingXia, China. BMC Gastroenterol 2016;16:2. [PMID: 26754840 DOI: 10.1186/s12876-015-0405-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Cervantes J, Hong B. The gut–lung axis in tuberculosis. Pathogens and Disease 2017;75. [DOI: 10.1093/femspd/ftx097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
2 Zhang AF, Miao YL. Strategies for remission induction of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2017; 25(33): 2938-2944 [DOI: 10.11569/wcjd.v25.i33.2938] [Reference Citation Analysis]
3 Kaplan GG, Ng SC. Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China. Lancet Gastroenterol Hepatol. 2016;1:307-316. [PMID: 28404201 DOI: 10.1016/s2468-1253(16)30077-2] [Cited by in Crossref: 67] [Cited by in F6Publishing: 30] [Article Influence: 11.2] [Reference Citation Analysis]
4 Bilski J, Wojcik D, Danielak A, Mazur-bialy A, Magierowski M, Tønnesen K, Brzozowski B, Surmiak M, Magierowska K, Pajdo R, Ptak-belowska A, Brzozowski T. Alternative Therapy in the Prevention of Experimental and Clinical Inflammatory Bowel Disease. Impact of Regular Physical Activity, Intestinal Alkaline Phosphatase and Herbal Products. CPD 2020;26:2936-50. [DOI: 10.2174/1381612826666200427090127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wei S, Sollano J, Hui YT, Yu W, Santos Estrella PV, Llamado LJQ, Koram N. Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia. Expert Review of Gastroenterology & Hepatology 2021;15:275-89. [DOI: 10.1080/17474124.2021.1840976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Chen LM, Bao CH, Wu Y, Liang SH, Wang D, Wu LY, Huang Y, Liu HR, Wu HG. Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease. J Neuroinflammation 2021;18:135. [PMID: 34127024 DOI: 10.1186/s12974-021-02175-2] [Reference Citation Analysis]
7 Cervantes J. Use your antibiotics wisely. Consequences to the intestinal microbiome. FEMS Microbiol Lett 2016;363:fnw081. [PMID: 27044298 DOI: 10.1093/femsle/fnw081] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 Pan Y, Liu Z, Wang Y, Zhang L, Chua N, Dai L, Chen J, Ho CL. Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments. Front Bioeng Biotechnol 2021;9:779018. [PMID: 34917601 DOI: 10.3389/fbioe.2021.779018] [Reference Citation Analysis]
9 Liu Z, Xie W, Li M, Liu J, Liang X, Li T. Intrarectally administered polaprezinc attenuates the development of dextran sodium sulfate-induced ulcerative colitis in mice. Exp Ther Med 2019;18:4927-34. [PMID: 31798714 DOI: 10.3892/etm.2019.8155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Bähler C, Vavricka SR, Schoepfer AM, Brüngger B, Reich O. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014. BMC Gastroenterol 2017;17:138. [PMID: 29197335 DOI: 10.1186/s12876-017-0681-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
11 Tsai YW, Fu SH, Dong JL, Chien MW, Liu YW, Hsu CY, Sytwu HK. Adipokine-Modulated Immunological Homeostasis Shapes the Pathophysiology of Inflammatory Bowel Disease. Int J Mol Sci 2020;21:E9564. [PMID: 33334069 DOI: 10.3390/ijms21249564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Bilski J, Mazur-Bialy A, Wojcik D, Surmiak M, Magierowski M, Sliwowski Z, Pajdo R, Kwiecien S, Danielak A, Ptak-Belowska A, Brzozowski T. Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.Biomolecules. 2019;9. [PMID: 31779136 DOI: 10.3390/biom9120780] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
13 Wan J, Wang X, Zhang Y, Xue X, Li Y, Liu Z, Han S, Chen M, Nie Y, Shi Y, Liang J, Wu K. 5-Aminosalicylic Acid Prevents Disease Behavior Progression and Intestinal Resection in Colonic and Ileocolonic Crohn's Disease Patients: A Retrospective Study. Can J Gastroenterol Hepatol 2021;2021:1412663. [PMID: 34422708 DOI: 10.1155/2021/1412663] [Reference Citation Analysis]
14 Yang M, Jia W, Wang D, Han F, Niu W, Zhang H, Shih DQ, Zhang X. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis. Dig Dis Sci 2019;64:1844-56. [PMID: 30949903 DOI: 10.1007/s10620-019-05580-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
15 Shah T, Shah Z, Baloch Z, Cui X. The role of microbiota in respiratory health and diseases, particularly in tuberculosis. Biomed Pharmacother 2021;143:112108. [PMID: 34560539 DOI: 10.1016/j.biopha.2021.112108] [Reference Citation Analysis]